Evaluation of Fucoxanthin Content in Popular Weight Loss Supplements: The Case for Stricter Regulation of Dietary Supplements
Mohammad Faisal Hossain, Mamoon Rashid, Thomas Burniston, Mohammed Ahmed, Winnie Wu, Kolawole Adeshina Kataye, Rajjit Sidhu, Michael Justice and Shamly Abdelfattah
Article Type: Original Research | First Published: September 05, 2019
Misbranded and counterfeit dietary supplements have been an issue on which the US Food and Drug Administration has been vigilantly regulating. The ubiquity of online- shoppable weight-loss supplements and their unrestricted consumption by obese people are serious matters of concern. Fucoxanthin, a brown-seaweed-extracted carotenoid has exhibited anti-obesity property in some clinical trials through its ability to over express uncoupling protein (UCP1) in the white adipose tissue, which leads to ...
OR-MRS Cannot be used for Morbidity in Laparoscopic Sleeve Gastrectomy
Evrim Kucur Tulubas
Article Type: Original Research | First Published: July 15, 2019
A reliable method to predict postoperative risks may improve surgical risks and ensure preventive precautions to reduce complication risks. American Society of Anesthesiologists (ASA) is a common method to determine surgical risk, but at first glance it appears to be insufficient to determine the risk of morbid obesity surgery. The greatest advantage of Obesity Surgery Mortality Risk Score (OS-MRS) is the use of five easily obtained clinical variables. A possible disadvantage is that it may only...